Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. (4th November 2015) - Linch, Stefanie; Kasiewicz, Melissa J; McNamara, Michael; Hilgart, Ian; Farhad, Mohammad; Redmond, William